| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
1 Department of Genetics, Rutgers University, Piscataway, New Jersey and 2 Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana
Requests for reprints: Changshun Shao, Department of Genetics, Rutgers University, 604 Allison Road, Piscataway, NJ 08854. Phone: 732-445-5406; Fax: 732-445-1147; E-mail: shao{at}biology.rutgers.edu.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The cellular responses to DNA damage caused by IR include activation of cell cycle checkpoints, DNA repair, apoptosis, and induction of a permanent arrest (7, 8). It seems that whichever pathway a cell is committed to, cell cycle arrest/DNA repair or apoptosis, depends on the severity of DNA damage, the cell type involved, and the environmental stimuli of the cell (9). Apoptosis plays an important protective role by eliminating cells with severely damaged or grossly abnormal genomes. Compromise in apoptosis can be permissive for the survival and ongoing division of cells that have failed to repair DNA damage or cells that have acquired abnormal genomes (10). If mutations occur in oncogenes and tumor suppressor genes, they may lead to carcinogenesis.
It remains unclear how different radiation schemes have different oncogenic consequences. Do different radiation schemes have different oncogenic effects because they have different mutagenic effects? The present work compared the mutagenic effects of split doses (4 x 1 Gy) versus a single dose (4 Gy) of X-rays on normal splenic T lymphocytes in vivo in B6C3F1 Aprt+/ mice. The mutant cells, caused by point mutation or by loss of heterozygosity (LOH), are recoverable by the virtue of their resistance to adenine analogue 2,6-diaminopurine (DAP; refs. 1113). The Aprt assay measures several pathways of LOH, including mitotic recombination, interstitial deletion, and chromosome loss. Although the majority of the spontaneous LOH events are derived from mitotic recombination, we found that interstitial chromosome deletions were remarkably induced by split doses of X-rays with weekly intervals, which is more efficient than of a single dose. We also found that the induction of apoptosis by IR is reduced in lymphocytes of mice that had been subjected to multiple exposures to X-rays. Reduction of apoptosis may facilitate the preferential accumulation of interstitial deletions spanning Aprt. We also presented evidence showing that the reduction of apoptosis is not mediated by p53.
| Materials and Methods |
|---|
|
|
|---|
Isolation and characterization of somatic mutants. Mice were sacrificed for necropsy 2 months after the last irradiation. The isolation of DAP-resistant (DAPr) lymphocytes was as described (13). As a reference, the frequency of Hprt mutant T cells, which is recoverable by their resistance to 6-thioguanine, was also measured (13).
Molecular and cytogenetic characterizations of DAPr clones were done as described (12, 13). In brief, the DAPr T-cell colonies were divided into two classes based on the loss (class I) or retention (class II) of the Aprt+ allele as determined by allele-specific PCR (12). Clones of class I were further characterized by genotyping the microsatellite markers flanking Aprt, in the order from centromere to telomere, D8Mit287, D8Mit4, Aprt, D8Tur1, D8Mit14, and D8Mit280. Colonies with LOH that initiated proximal to Aprt and continue to the distal end of chromosome 8 and with two normal copies of chromosome 8 in diploid metaphases were assigned to the category of mitotic recombination.
Class I colonies that remained heterozygous at loci flanking Aprt were presumably the result of interstitial deletion spanning the Aprt+ allele (only one Aprt allele containing the neo insert remains) or gene conversion or recombination with double crossover (two Aprt alleles, each containing a copy of neo). To determine the copy number of the neo insertion and infer the likelihood of interstitial deletion or gene conversion or recombination with double crossover, these colonies were characterized with quantitative real-time PCR as described (14).
Spleen cell isolation and nuclear extract preparation. Individual spleens were crushed in RPMI 1640, and cell suspension was passed through a 70-µm cell strainer and washed with ice-cold PBS. Nuclear protein extracts were prepared from spleen cells as described (15, 16). Protein concentration was determined by the Bradford assay (17).
Western blotting. Equal amounts of nuclear extract from spleen cells were separated with SDS-PAGE gels and transferred onto polyvinylidene difluoride membranes. Membranes were blocked at room temperature for 30 min in blocking buffer (3% nonfat dry milk in PBS containing 0.1% Tween 20) and incubated at 4°C overnight with primary antibody diluted in blocking buffer. After five washes with PBS containing 0.1% Tween 20, membranes were incubated at room temperature for 1 h with secondary antibody diluted in blocking buffer. Immunoblots were visualized by enhanced chemiluminescence. Primary antibodies used in this study were rabbit anti-phosphorylated p53 at serine 15 (Cell Signaling Technology, Danvers, MA) and rabbit antiß-actin (Abcam, Cambridge, MA).
Enumeration of circulating leukocytes. Three microliters of blood sample were collected from mouse tail veins before and 24 h after a 1-Gy X-ray. The blood samples were immediately resuspended and stained in a 57-µL solution containing 0.01% crystal violet and 1.5% acetic acid and counted with light microscopy on a modified Neubauer hemocytometer. The survival of circulating leukocytes was calculated by dividing the leukocyte count obtained 24 h after X-ray exposure with that obtained before the exposure.
Measurement of apoptosis of splenic lymphocytes. Apoptosis of splenic lymphocytes was examined with a kit that measures apoptosis based on terminal deoxyribonucleic transferase-mediated dUTP nick end labeling (TUNEL) technology (Roche Applied Science, Indianapolis, IN). Mice were sacrificed at different time points after X-irradiation. Spleens were obtained and placed in ice-cold RPMI 1640. Splenic lymphocytes were isolated as described (13) and were fixed in 2% paraformaldehyde (in 1 x PBS) for 1 h at room temperature. Cells were washed thrice with PBS, resuspended in permeabilization solution (0.1% triton X-100, 0.1% sodium citrate, freshly made), and incubated on ice for 2 min. Cells were washed twice with PBS, resuspended in TUNEL reaction mixture, and incubated at 37°C for 1 h. Samples were washed twice with PBS and analyzed under a fluorescence microscope.
Real-time PCR for quantification of gene expression. Total RNA from isolated splenic lymphocytes was purified using the RNeasy kit (Qiagen, Valencia, CA) and reverse transcribed using the TaqMan reverse transcription reagent kit (Applied Biosystems, Foster City, CA). The expression of selected genes was quantified as previously reported (18). Expression levels were calculated as a ratio of the mRNA level for a given gene relative to the mRNA level for glyceraldehyde-3-phosphate dehydrogenase in the same cDNA.
The primer sequences are as follows:
Statistics. Because of the great variation in mutant frequencies in each group, the frequencies of DAPr and 6-TGr variants in irradiated and unirradiated mice were compared using the Mann-Whitney U test. Comparisons of the relative fraction of class I and class II variants and the mutational spectra of class I and class II variants in mice treated with different exposure doses or fractionations were done with contingency tables. Significance levels were determined with
2 test using MINITAB software (Minitab, Inc., State College, PA).
| Results |
|---|
|
|
|---|
|
We then tested whether the induction of Aprt mutation would be affected when the radiation was to be fractionated. When a total dose of 4 Gy was split into four daily 1-Gy fractions, it produced a 1.7-fold increase in the median frequency of DAPr variants over the unirradiated controls. Again such increase was not statistically significant (P > 0.1; Fig. 1B). In contrast, when the total dose of 4 Gy was split into four 1-Gy weekly fractions, the frequency of DAPr variants was elevated by
3-fold (P < 0.001; Fig. 1B). These findings suggest that the mutagenic consequences induced by IR were dependent on the radiation scheme and the tested target (or reporter) genes. Although IR delivered within a narrow time window was very efficient in inducing mutations at the Hprt locus, it was less efficient in inducing mutations that span the Aprt locus.
Preferential induction of chromosomal deletions at the Aprt locus after fractionated exposures at weekly intervals. To determine the mechanisms of mutagenesis that contribute to the increase in the frequency of the DAPr variants in mice exposed to IR, we first divided these variants into two classes, class I and class II, by allele-specific PCR, as described in Materials and Methods. Class I variants can be caused by chromosome loss, mitotic recombination, interstitial deletion, and gene conversion. Class II variants are usually the results of intragenic point mutation and probably epigenetic inactivation. As shown in Table 1
, both class I and class II variants were increased in mice exposed to 4 Gy of IR. Molecular and cytogenetic characterization of class I DAPr variants indicated that a single dose of 4 Gy significantly induced interstitial deletion/gene conversion events compared with controls (P = 0.003; Table 2
). Although the category of interstitial deletion/gene conversion accounted for 4% of class I variants in unirradiated mice, it accounted for 22% in mice with a single 4-Gy exposure (Table 2). Taking into consideration the increase in overall frequency of DAPr variants, the frequency of T-cell variants derived by interstitial deletion/gene conversion in mice with a single 4-Gy dose was 7.9 x 106, which is
10-fold higher than that of control mice (0.8 x 106). It should be noted that the frequency of class I variants caused by mitotic recombination was nearly 2-fold higher in mice receiving a single 4-Gy exposure. The increase, however, was less distinct when compared with that of interstitial deletion/gene conversion (Table 2).
|
|
22-fold higher than that of controls (17.4 x 106 versus 0.8 x 106). The sizes of the deletions were determined by genotyping markers D8Tur1 and D8Mit14 that are distal to Aprt. Six of eight clones in the group of 4 x 1 Gy at weekly intervals exhibited LOH at D8Tur1. Similarly, six of seven clones in the 4-Gy group also had LOH at D8Tur1. The exposure scheme of 4 x 1 Gy at daily intervals had a similar effect as the single 4-Gy dose in its induction of interstitial deletion/gene conversion (Table 2). Thus, although the exposure scheme of 4 x 1 Gy at weekly intervals was the least efficient in inducing mutations at the X-linked Hprt locus (Fig. 1A), it was the most efficient in inducing chromosomal deletions spanning or within Aprt on chromosome 8.
Sequencing analysis of Aprt showed that small deletions/insertions accounted for many of class II variants (Table 3 ). The elevation of such genetic alterations seemed to be the highest in the group of 4 x 1 Gy at weekly intervals (12.9 x 106). Both intragenic deletions/insertions in class II variants and the interstitial deletions in class I variants were probably caused by errors during nonhomologous end joining of DNA double-strand breaks. When 4 Gy of X-rays were split into 4 x 1 Gy at weekly intervals, it becomes more efficient in inducing deletions that are derived from erroneous repair of double-strand breaks mediated by nonhomologous end joining.
|
|
40% of the level before exposure, the subsequent exposures were less effective, reducing it to
70% of the level the day before exposure, suggesting that surviving cells became more resistant to subsequent X-ray exposures. Interestingly, compared with a 60% reduction in leukocyte numbers at 24 h after the first exposure in wild-type mice, the reduction was only 30% in p53/ mice (Fig. 2B, inset), suggesting that diminished leukocyte numbers after X-irradiation are partly mediated by p53.
Taken together, repeated X-ray exposures select for reduced apoptosis in lymphoid cells and peripheral leukocytes. When apoptosis is compromised, cells with certain types of residual DNA damage may survive and proliferate, leading to a higher mutational load. This is apparently the case for mutations involving the Aprt locus in irradiated mouse T cells.
Reduced apoptosis after repeated IR is p53 independent. It has been well recognized that p53 is the key regulator of apoptosis in cells of lymphoid origin. Apoptosis in lymphoid cells induced by IR is usually greatly reduced in p53 null mice (2225). Also, the preferential induction of interstitial deletions in the 4 x 1 Gy mice highly resembles the mutational spectrum of DAPr T cells of p53/ mice irradiated with a single 4-Gy X-ray exposure, as we reported previously (14). Whereas chromosomal deletions accounted for only 9% of the class I T-cell variants in untreated p53/ mice, they were increased to 46% in irradiated p53/ mice, representing a 40-fold increase in mutant frequency (14). Collectively, these findings suggest that down-regulation of p53 may be responsible for the reduction of apoptosis selected by the repeated exposures to IR. To test this hypothesis, we measured, by Western blot, the level of phosphorylated p53 at serine 15, an indicator of p53 activation in response to IR (27, 28), in splenic cells at different time points after their exposure to IR. However, contrary to our prediction, we observed no differences in the levels of p53 activation for all time points tested whether or not the mice had received three exposures to X-rays previously. It was evident that p53 activation started within 1 h of exposure to X-rays, peaked at 3 h and then subsided. It became undetectable at 24 h. The same pattern was observed for both groups (Fig. 3A ).
|
Thus, although the induction of apoptosis by IR is reduced in mice irradiated weekly, this reduction is not mediated by p53. Supporting this notion is the observation that p53 activation and its function were induced similarly in splenocytes regardless of their previous exposure to X-rays. Also, only the delayed apoptosis, but not the early apoptosis, was reduced in the 4 x 1 Gy group when compared with the 1-Gy group. At the time point when the delayed apoptosis peaks, p53 induction was undetectable. Consistent with our findings, a delayed wave of apoptosis, 20 h after exposure to IR, was observed in T cells of both p53 wild-type and p53 null mice (29).
p53 also functions in suppressing spontaneous and IR-induced mitotic recombination (14, 30). Although mitotic recombination mutants were increased 7-fold in T cells of p53/ mice exposed to a single 4-Gy exposure to X-rays (14), they were increased only 2-fold in those of 4 x 1 Gy mice, providing additional evidence that p53 function is retained in 4 x 1 Gy mice.
| Discussion |
|---|
|
|
|---|
radiation (31). In this study, we evaluated whether different radiation schemes would have different mutagenic effects on T cells. We found that split doses of X-rays given at weekly intervals were more efficient in inducing Aprt mutations in T cells than a single dose or split doses with daily intervals. In particular, interstitial deletions were preferentially observed. Although 4 Gy of X-rays given in a single exposure generated a 10-fold increase in the frequency of interstitial deletions, the same dose, if fractionated at weekly intervals but not at daily intervals, led to a 22-fold increase (Table 2). Thus, the induction of deletion mutations at Aprt locus is dependent on radiation exposure schemes. Interestingly, the same radiation schemes had opposite effects on Hprt and Aprt locus. Although a single dose or split doses with daily intervals were more potent than split doses with weekly intervals at the X-linked Hprt locus, the opposite was true for the induction of mutations at the autosomal Aprt locus in splenocytes; we don't know if this finding applies to other autosomal and X-linked loci. In one study (32), a fractionated radiation scheme led to a greater induction of lymphomas, which suggests that, perhaps, deletions involving other autosomal loci might be more common after fractionated irradiation. It is probable that deletions spanning Hprt on X chromosome are induced differently from those on autosomes, especially if illegitimate recombination and/or cross-talk between homologues are involved in the generation of deletion mutations. In addition, chromosomal location and the size of the deletion, as well as the genes involved, may all affect the in vivo proliferation status of a deletion mutant. Thus, the presence or absence of genes that are cis-linked to a reporter gene, Aprt or Hprt, may affect the survival and proliferation of the deletion mutants. Cdt1, which is located only 1.5 kb from the 3' end of Aprt, is essential for replication initiation (33). Cells with deletions that extend into Cdt1 region will presumably have a disadvantage in proliferation. The proliferation and consequently the recovery of such deletion mutants may become possible only if apoptosis is reduced. Indeed, deletions that extended beyond Cdt1 and spanned several megabases on chromosome 8 were rarely observed in cells recovered from p53+/+ mice but were frequently detected in those from p53/ and p53+/ mice (30). In this study, almost all the deletion mutations extended beyond D8MitTur1, 1 kb from the 5' end of Aprt, although it is unknown whether or not the deletions extended to the Cdt1 region on the 3' end.
We observed previously that the frequency of Hprt mutant T cells were similarly induced by a single dose of X-rays regardless of p53 status (14) and p21 status.4 However, the induction of Aprt mutant frequency in T cells by the same dose was greatly affected by the status of p53. Although a single dose of X-rays only had a modest effect on the induction of Aprt mutants in p53 wild-type mice, such mutations were induced 8-fold by the same treatment in p53/ mice (14), indicating that this locus-specific induction of somatic mutations is determined by p53 status. Because somatic cells in vivo vary in the level of p53 expression (34), it is expected that every time these cells are exposed to IR, those with higher levels of p53 would be preferentially selected against as a consequence of their higher capacity to undergo apoptosis. However, although we indeed found that the induction of apoptosis is reduced in the splenic cells in the mice that received repeated X-ray exposure, the dynamics of p53 activation was not altered in spite of the difference in the delayed apoptosis. Consistent with the normal induction of p53, mitotic recombination is not as highly increased in 4 x 1 Gy mice as in p53/ mice (14). Collectively, these data suggest that higher p53 levels are not selected against by repeated exposures to X-rays. This is unexpected. One possible explanation is that the cells that repopulate lymphoid tissues after radiation exposure are derived from stem cells in which p53 does not express and, thus, are not subjected to p53 mediated apoptosis.
Nevertheless, the induction of apoptosis is decreased in mice that had received split doses of X-rays with weekly intervals although p53 activation is normal. This reduced apoptosis probably contributes to the increase of Aprt mutations in T cells of mice. It has been reported that ectopic expression of Bcl-2 or Bcl-x leads to increased radioresistance in both p53 wild-type cells and p53 mutant cells (35). Importantly and consistent with our findings, LOH mutations at TK1 locus were elevated markedly by IR when Bcl-2 or Bcl-xL expression was increased; mutations at Hprt locus, on the other hand, were increased only slightly (35).
Although apoptosis has been recognized as the safeguard mechanism for the maintenance of genomic integrity (10), there have been very few studies that systematically evaluate the mutational consequences caused by failure of apoptosis. Our study provides the first evidence that associates decreased apoptosis with increased mutation accumulation in vivo. In a separate study, we found that in p21-null mice whose lymphocytes are more sensitized to IR-induced apoptosis, somatic mutations at Aprt locus in T cells are reduced.4 Collectively, these findings implicate the role of apoptosis in the prevention of some types of somatic mutations.
The mutagenicity of different radiation schemes we report here is correlated to the lymphomagenic activity of IR that was reported by Kaplan and Brown (32), who studied lymphoma incidence and latent period in C57 black mice treated with whole body X-irradiation in a single exposure or equal fractions at different time intervals. They showed that although there was a rather gradual increase in lymphoma incidence with increased dosage when it was given in a single exposure or divided into four fractions at daily intervals, the same total dose, when separated into four fractions given at intervals of 4 to 8 days, yielded a much higher lymphoma incidence and a shorter latent period. Shimada et al. (36) showed that X-irradiation fractionated at weekly intervals (4 x 1.6 Gy) was very efficient in inducing thymic lymphomas in B6C3F1 mice, and multiloci LOH events were more common in the induced lymphomas than in spontaneous lymphomas. Our results provide one possible mechanistic explanation for the differential induction of lymphomas by the different radiation schemes. Our results suggest that both reduced apoptosis and increased somatic mutations contribute to the increased frequency of lymphomas in mice treated with similar fractionation schemes.
| Acknowledgments |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
We thank an anonymous reviewer for providing many critical comments and helpful suggestions.
| Footnotes |
|---|
4 Shao, Liang, Chen, and Tischfield, unpublished data. ![]()
Received 4/24/06. Revised 12/12/06. Accepted 12/22/06.
| References |
|---|
|
|
|---|
-irradiated mouse. Int J Radiat Biol 1994;66:31926.[Medline]
-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 2005;106:41318.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |